Eltrombopag (Promacta)

eltrombopag · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eltrombopag (Promacta), covering 2025-06-10 to 2025-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA) [Phase 2, Phase 3]